<DOC>
	<DOCNO>NCT02554214</DOCNO>
	<brief_summary>This prospective , descriptive , mono-center , non-comparative study . A sample 30 patient satisfy entry criterion estimate appropriate provide safety performance data study . The objective study verify performance safety Glafkos adjustable glaucoma drainage device system . Performance measure assess possibility adjust intra-ocular pressure post-operatively . Safety measure incidence severity adverse event . The Glafkos device implant combination seton tube . The implant place scleral flap , manner analogous ex-Press device ( Alcon ) . The distal end drain tube link seton drain tube , link plate place extraocular muscle , create filter space orbit ( filter bleb ) .</brief_summary>
	<brief_title>Pilot Clinical Trial New Adjustable Glaucoma Drainage Device</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<criteria>1 . Patient must 18 year age old . 2 . Patient shall suffer primary open angle glaucoma , pseudoexfoliative glaucoma , refractory glaucoma fail previous filtering surgery , study eye . Diagnosis base glaucomatous optic neuropathy , Shaffer angle great 2 see gonioscopy , visual field defect attribute glaucoma . 3 . Eye treat shall phakic pseudophakic active ocular disease disorder except incipiens cataract . Prior ophthalmic surgery study eye shall perform 3 month enrollment study . 4 . Patient condition indicate primary secondary filtration surgery . 5 . Presence ocular hypertension define intraocular correct pressure ( IOP ) &gt; 20 mmHg study eye , maximally tolerated medication . The IOP level shall obtain 2 consecutive measurement ( take day ) prior surgery . 6 . Distance Snellen best correct visual acuity ( BCVA ) good 0.6 fellow eye . 7 . For first three subject Snellen BCVA study eye 0.5 less . In addition , visual field define Mean Defect ( MD ) shall high 10 dB . 8 . Optic neuropathy exclusively attributed glaucoma . 9 . Patient agree sign write inform consent prior enter investigation . 10 . Patient able willing complete postoperative followup requirement . 1 . Diagnosis neovascular glaucoma , congenital glaucoma . 2 . History previous intraocular surgery study eye refer limited extraocular muscle ( strabismus ) , corneal transplant , retinal surgery . 3 . Proliferative severe nonproliferative retinopathy either eye . 4 . Congenital anomaly anterior chamber angle study eye . 5 . Optic neuropathy glaucoma study eye . 6 . Patient retinal vein occlusion study eye . 7 . Patient retinal artery occlusion study eye . 8 . Patient corneal opacification irregularity may interfere optic nerve evaluation IOP measurement study eye . 9 . Patient history severe eye trauma study eye . 10 . Patient ocular malformation microphthalmia study eye . 11 . Patient concurrent inflammatory/infective eye disorder study eye . 12 . Patient sign past present uveitis ( anterior/posterior ) . 13 . Patient severe systemic disease disable condition chronic renal failure , post organ transplant . 14 . Patient participate another clinical trial participate another clinical trial le 3 month prior enter investigation . 15 . Patient pregnant , breastfeed unable make decision participate clinical investigation ( e.g . mentally ill person , mentally handicap person )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>